Hospira initiated the recall after a routine simulation of its manufacturing process discovered the potential for microbial growth, suggesting microorganisms may be in the products.
PharMedium Services on June 26 recalled nearly 20 lots of its potassium phosphate and succinylcholine chloride injections distributed to healthcare facilities across the country. PharMedium’s injectables are compounded using some Hospira products.
Fagron Sterile Services recalled three lots of its succinylcholine chloride injection at the hospital and clinic level June 23. The company purchases Hospira products and repackages them under their own label.
Neither PharMedium nor Fagron Sterile Services have received reports of adverse events associated with the recalled injectable drugs.
More articles on supply chain:
Viewpoint: 4 insights into postapproval monitoring of medical devices
6 drugmakers in the headlines
Philips acquires noninvasive neurodiagnostics company for $36M
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.